Phase I oncology trials: risks and benefits vary by trial type

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1042卷 / 1期
关键词：
Public Health; Toxic Event; Cancer Therapy; Chemotherapeutic Agent; Stable Disease;
D O I：
10.2165/00128415-200510420-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [21] Risks and benefits of phase I trials: Eighteen-year experience from a single institution.
    Kam, Audrey E.
    Chaudhary, Imran
    Ghalib, Mohammad Haroon
    Shah, Umang H.
    Swami, Umang
    Kuo, Dennis Yi-Shin
    Hwang, Caroline
    Elrafei, Tarek N.
    Cohen, Bruce
    Gartrell, Benjamin Adam
    Kaledzi, Elizabeth
    Chuy, Jennifer W.
    Cheng, Haiying
    Rajdev, Lakshmi
    Haigentz, Missak
    Mani, Sridhar
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Risks and benefits of phase I trials: Twelve-years experience from a single institution.
    Swami, U.
    Ghalib, M. H.
    Chaudhary, I.
    Hou, J. Y.
    Aparo, S.
    Einstein, M. H.
    Goldberg, G. L.
    Elrafei, T. N.
    Gajavelli, S.
    Cohen, B.
    Rajdev, L.
    Kaubisch, A.
    Haigentz, M.
    Mani, S.
    Goel, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship
    Ruiz, Jenny
    Kelly, Rebecca K.
    Aplenc, Richard
    Laetsch, Theodore W.
    Seif, Alix E.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (05)
  • [24] Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
    Douma, Joeri A. J.
    Buffart, Laurien M.
    Sedhom, Ramy
    Labots, Mariette
    van der Houven van Oordt, Willemien C.
    Skardhamar, Mikkjal
    De Felice, Anthony
    Lee, Esther
    Dharmaraj, Divya
    Azad, Nilofer S.
    Carducci, Michael A.
    Verheul, Henk M. W.
    CANCERS, 2021, 13 (10)
  • [25] Barriers to clinical trials vary according to the type of trial and the institution - Reply
    Dilts, David M.
    Sandler, Alan B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1634 - 1634
  • [26] Evaluation of Enrollment in Oncology Phase I Clinical Trials
    van der Biessen, A. J.
    Cranendonk, M. A.
    van der Holt, B.
    Verweij, J.
    de Jonge, M. J. A.
    Mathijssen, R. H. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S161 - S161
  • [27] Increasing complexity in oncology phase I clinical trials
    Malik, Laeeq
    Lu, David
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 519 - 523
  • [28] ONCOLOGY PHASE I TRIALS AT SHIZUOKA CANCER CENTER
    Murakami, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 10 - 10
  • [29] Participation of women in phase I oncology clinical trials
    Vidal, L.
    Berg, R.
    Yang, Z.
    Moss, K. R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Improving Patient Selection for Phase I Oncology Trials
    Voskoboynik, Mark
    Arkenau, Hendrik-Tobias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (28) : 3198 - 3199
12345